Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors?

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study – Circulation (free PDF)

Commentaries: Risk of HF and Death in Patients on SGLT-2 Inhibitors – American College of Cardiology, Latest in Cardiology (free) AND SGLT2 inhibitors may have class effect for reduction of cardiac risk – ACP Diabetes Monthly (free)

Observational data suggests these class of drugs may be associated with lower risk of heart failure and deaths compared to other drugs.